HBMN — HBM Healthcare Investments AG Income Statement
0.000.00%
Last trade - 00:00- CH₣1.16bn
- CH₣1.26bn
- CH₣42.01m
- 58
- 34
- 55
- 45
Annual income statement for HBM Healthcare Investments AG, fiscal year end - March 31st, CHF millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 917 | -37.6 | -118 | 23.2 | 42 |
| Cost of Revenue | |||||
| Gross Profit | 770 | -72.5 | -145 | 0.474 | 19.5 |
| Selling / General / Administrative Expenses | |||||
| Operating Interest Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 158 | 37.7 | 26.1 | 22.7 | 22.2 |
| Operating Profit | 759 | -75.3 | -144 | 0.52 | 19.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 756 | -78 | -146 | -1.08 | 18.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 756 | -78 | -146 | -1.08 | 18.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 756 | -78 | -146 | -1.08 | 18.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 756 | -78 | -146 | -1.08 | 18.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 109 | -11.2 | -21 | -0.156 | 2.72 |
| Dividends per Share | |||||
| Special Dividends per Share |